Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2022 Earnings Conference Call March 1, 2023 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications & IR Sharon Mates - Founder, Chairman, and CEO Mark Neumann - EVP & Chief Commercial Officer Lawrence J. Hineline - SVP, Finance and CFO Suresh Durgam - EVP & CMO Conference Call Participants Andrew Tsai - Jefferies Brian Abrahams - RBC Capital Markets Unidentified Analyst - J.P. Morgan Chase Michael DiFiore - Evercore ISI Marc Goodman - SVB ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36274 Intra-Cellular Therapies, Inc. (Exact name of registrant as specified in its charter) Delaware 36-4742850 (S ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Juan Sanchez - VP, Corporate Communications & IR Sharon Mates - Co-Founder, Chairman, CEO & President Mark Neumann - EVP & Chief Commercial Officer Lawrence Hineline - SVP, Finance, CFO, Treasurer & Assistant Secretary Suresh Durgam - EVP & Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Brian Abrahams - RBC Capital Markets Michael DiFiore - Evercore ISI A ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q2 2022 Earnings Conference Call August 9, 2022 8:30 AM ET Company Participants Juan Sanchez - Vice President, Corporate Communications and Investor Relations Sharon Mates - Chairman and Chief Executive Officer Mark Neumann - Executive Vice President and Chief Commercial Officer Suresh Durgam - Executive Vice President Chief Medical Officer Larry Hineline - Senior Vice President and Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Jess ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Juan Sanchez - Vice President, Corporate Communications and Investor Relations Sharon Mates - Chairman and Chief Executive Officer Mark Neumann - Executive Vice President and Chief Commercial Officer Suresh Durgam - Executive Vice President Chief Medical Officer Larry Hineline - Senior Vice President and Chief Financial Officer Conference Call Participants Andrew Tsai - Jefferies Jessic ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q4 2021 Earnings Conference Call March 1, 2022 8:30 AM ET Company Participants Juan Sanchez – Vice President-Corporate Communications and Investor Relations Sharon Mates – Chairman and Chief Executive Officer Mark Neumann – Executive Vice President and Chief Commercial Officer Larry Hineline – Senior Vice President and Chief Financial Officer Conference Call Participants Jessica Fye – JPMorgan Brian Abrahams – RBC Capital Markets Andrew Tsai – Jefferies Mike DiFi ...

Corporate Presentation February 2022 Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, our plans to commercialize CAPLYTA f ...

Corporate Presentation January 2022 Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, our plans to commercialize CAPLYTA fo ...

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Juan Sanchez - Vice President of Corporate Communications and Investor Relations Sharon Mates - Founder, Chairman and Chief Executive Officer Mark Neumann - Executive Vice President and Chief Commercial Officer Larry Hineline - Senior Vice President of Finance and Chief Financial Officer Suresh Durgam - Senior Vice President and Chief Medical Officer Conference Call Participants Bri ...

Corporate Presentation September 2021 Safe Harbor Statement 2 This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements are ...